Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000059

COFO and Secretary sold 22,844 shares at an average $17.62 ($402,420)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Schuth Alexander O. · COFO and Secretary

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-13 Sale : show line 1 in the form 10b5-1 −2,716 $17.29 $46,960 207,469 D
2024-02-14 Sale : show line 2 in the form 10b5-1 −20,128 $17.66 $355,460 187,341 D
Open-market sales · 22,844 sh · avg $17.62 · $402,420
Loading xslF345X05/wk-form4_1708049627.xml…